Keep Updated May 2017

Otsuka announces preliminary results of Phase 3 data on tolvaptan

Otsuka Pharmaceutical Co., Ltd. (Otsuka) has released its preliminary results from an additional Phase 3 clinical trial of tolvaptan in adult patients with autosomal dominant polycystic kidney disease (ADPKD). Primary and key secondary endpoints were positive for tolvaptan vs. placebo […]

PKD Foundation |

PKD Foundation awards fellowships to promising PKD researchers

To move us forward in finding treatments, the Foundation has selected four outstanding researchers as recipients of the 2017 PKD Foundation Fellowships. The fellowships recognize early-career scientists whose achievements and potential identify them as rising stars – the next generation […]

PKD Foundation |

Washington summary May 2017

Health Care Reform On May 4, the House passed HR 1628, the American Health Care Act (AHCA) by a vote of 217-213. The bill would replace the current Affordable Care Act (ACA, or Obamacare). Senate Majority Whip John Cornyn (R-TX) […]

PKD Foundation |